Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Voyager Therapeutics (VYGR) Return on Invested Capital (2017 - 2025)

Voyager Therapeutics (VYGR) has disclosed Return on Invested Capital for 5 consecutive years, with 0.63% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital fell 37.0% to 0.63% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.63% through Dec 2025, down 37.0% year-over-year, with the annual reading at 0.53% for FY2025, 22.0% down from the prior year.
  • Return on Invested Capital hit 0.63% in Q4 2025 for Voyager Therapeutics, down from 0.61% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.67% in Q1 2023 to a low of 0.63% in Q4 2025.
  • Historically, Return on Invested Capital has averaged 0.16% across 3 years, with a median of 0.27% in 2024.
  • Biggest five-year swings in Return on Invested Capital: crashed -118bps in 2024 and later increased 14bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.13% in 2023, then crashed by -298bps to 0.27% in 2024, then tumbled by -138bps to 0.63% in 2025.
  • Business Quant data shows Return on Invested Capital for VYGR at 0.63% in Q4 2025, 0.61% in Q3 2025, and 0.48% in Q2 2025.